• News

No Increased VTE Risk with Continued HT During Gender-Affirming Surgery

  • Healio
  • New York, NY
  • (January 15, 2021)

Transgender and gender nonbinary patients who remain on estrogen hormone therapy during gender-affirming surgery do not have an increased risk for venous thromboembolism, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Learn more